$DTM

DT Midstream Inc. reports Q3 earnings Thursday, with analysts expecting $1.13 EPS on $328.2M revenue. Investors focus on project timelines and approvals, particularly the MIST Southbound Phase 1 project. The stock has fallen 16% in three months, trading near $128.54 with a consensus price target of $150.40. Analysts highlight the importance of project updates for justifying the valuation.

BofA Securities reduced DT Midstream's (NYSE:DTM) price target to $145 from $155, citing slower backlog growth due to datacenter NIMBY concerns. The stock has fallen 16% quarter-to-date and trades at a P/E ratio of 27.34. Analysts have mixed views, with some revising earnings downward and others seeing long-term opportunities. DT Midstream reported adjusted EBITDA of $305 million for Q2, reaffirmed its full-year outlook, and announced $300 million in new projects.

Morgan Stanley maintained its Overweight rating for DT Midstream (DTM) but lowered its price target from $170 to $164. GuruFocus values DTM at $127.14, slightly undervalued compared to its current price of $125.34. The company has a GF Score of 84, indicating strong performance, with notable insider buying activity.

Jefferies raised its price target for DT Midstream (NYSE:DTM) to $150 from $145, citing project outlook and demand growth. The stock trades at a P/E ratio of 26.24, with analyst targets ranging from $121 to $170. DT Midstream reported Q2 adjusted EBITDA of $305 million and reaffirmed its full-year outlook. Analysts have mixed opinions on the stock's future.

Goldman Sachs reduced its price target for DT Midstream (NYSE:DTM) to $121 from $127, maintaining a Sell rating. The stock is currently trading at $126.55, which is considered overvalued relative to its Fair Value estimate. Goldman expects Q3 2026 EBITDA of $300 million, in line with consensus. Full-year 2026 EBITDA is forecasted at $1,221 million, slightly above consensus. The firm noted a 13% stock decline over the past three months, reflecting growth timing concerns.

Morgan Stanley upgraded DT Midstream Inc (DTM) to Overweight with a $170 target price, citing attractive valuation. DTM offers a 2.61% dividend yield but is 2.8% overvalued per GF Value™. Its GF Score™ is 84/100, with strong growth and momentum. Insider activity is neutral, while institutional interest is mixed.

JPMorgan upgraded Meta (META) to Overweight with an $820 target. Piper Sandler initiated AMD and NVIDIA (NVDA) with Overweight ratings. Gold hit $4,400, Bitcoin rose to $78,000. Brent Crude surpassed $100. Markets fell due to rising rates and geopolitical tensions. August inflation data is expected to impact Fed rate hike decisions.

Midstream companies are expanding natural gas infrastructure due to increased production and demand. Key projects include new pipelines and processing plants, with a collective $160B backlog. Companies like Kinder Morgan, Energy Transfer, and Targa Resources are involved, raising financial guidance. Permian Basin's gas output is growing, driving infrastructure investments.

UBS upgraded SolarEdge (SEDG) to Buy with a $42 target, citing FCC benefits. Wolfe upgraded DT Midstream (DTM) to Outperform with a $145 target. Piper upgraded Neogen (NEOG) to Overweight with a $14 target. UBS upgraded Argenx (ARGX) to Buy with a $1,400 target. National Bank upgraded Scotiabank (BNS) to Outperform with a C$142 target. JPMorgan and BofA downgraded Intuit (INTU) to Neutral with a $331 target. Truist downgraded Dick's Sporting (DKS) and Nike (NKE). Wells downgraded GoDaddy (GDDY).

DT Midstream (DTM) rose 4.1% after Wolfe Research upgraded it to Outperform from Peer Perform, setting a $145 price target. The firm cited the company's growth prospects and improved valuation.